Inside This Issue - News
When the acquisition of Shoppers Drug Mart (SDM) by Loblaw Cos. was concluded in March of this year, no changes in the senior management of either company were made, but commentators speculated that some significant shifts in responsibility would soon follow. Those predictions proved justified.
CVS Caremark Corp. has agreed to acquire Miami-based Navarro Discount Pharmacy, the largest Hispanic-owned drug chain in the United States.
Kermit Crawford, president of pharmacy, health and wellness at Walgreen Co., will retire at the end of this year. He will, however, continue to serve as a senior counselor to president and chief executive officer Greg Wasson.
Walmart has promoted Greg Foran to the position of president and chief executive officer of Walmart U.S., replacing Bill Simon.
Target Corp. has appointed Brian Cornell chief executive officer and chairman of the board.
Darren Karst has been named executive vice president and chief financial officer of Rite Aid Corp. He succeeds Frank Vitrano, who is retiring.
Walgreen Co. has expanded its Balance Rewards loyalty program with new features that promote and support healthful behaviors.
Company also extends distribution pact with McKesson
CVS/pharmacy has become the first pharmacy in the nation to earn the new Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry.
Warren Jeffery has returned to Rexall Pharma Plus as chief operating officer. He had retired from the chain in 2011 as chief development officer and interim chief merchandising officer.
Conflicting court rulings on the Affordable Care Act are unlikely to have an immediate impact on pharmacies, says Don Bell, senior vice president of legal affairs and general counsel at the National Association of Chain Drug Stores.
In a move that caught the investment community by surprise, Dollar Tree Inc. has agreed to acquire Family Dollar Stores Inc. for about $9.2 billion in cash and stock.
Diplomat Specialty Pharmacy last month filed for a $100 million initial public offering and acquired MedPro Rx Inc., which is focused on specialty infusion therapies, including immune globulin.
More patients are turning to retail clinics for chronic and preventive care, a new Walgreen Co. study shows.